Delivery Order SPE2DB24D2011-SPE2DB25FBPRH
Award Date
12/31/24
Potential Completion Date
1/2/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,387.32 delivery order contract is for the supply of 1,000 units of Losartan Potassium 25 mg tablets, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of February 27, 2023.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,677,679 units of Losartan Potassium 50 mg tablets. The $1,996.04 firm fixed price delivery order has an ultimate completion date of April 24, 2023 and was awarded on April 21, 2023. The contract is not set aside for any specific business type.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083 firm-fixed-price delivery order is for the supply of 4,564,015,207 units of Losartan Potassium 50 mg tablets. The contract has an ultimate completion date of March 20, 2024 and does not have any set-aside designation, indicating open competition.
AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,263.54, is a Delivery Order for the supply of 50 mg Losartan Potassium tablets. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,907.53 firm fixed-price delivery order is for 1,000 units of Losartan Potassium 100 mg tablets, with a completion date of August 8, 2022.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of Losartan Potassium 100 mg tablets to the Defense Logistics Agency (DLA). The $2,154.97 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. It does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of Losartan Potassium 100 mg tablets to the Defense Logistics Agency (DLA). The $2,470.56 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company that is a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 25, 2022. There was no set-aside designation, indicating the contract was awarded through full and open competition.
AmerisourceBergen...
The federal contract award SPE2DB20D3505|SPE2DB25FT6T6 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,790,367 units of Losartan Potassium 100 mg tablets. The $1,116.69 firm-fixed-price contract has a completion date of December 24, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a delivery order contract award to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,537.34 firm fixed-price contract is for the delivery of 4,565,391,981 units of Losartan Potassium 50 mg tablets by August 9, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $7,255.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,560,404 units of Losartan Potassium 100 mg tablets, a cardiovascular medication. The contract has a firm fixed-price pricing type and an ultimate completion date of March 29, 2023.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...